The trajectory of companies tied to Viagra's history presents a intricate investment picture . While the initial success generated substantial gains, generic copies have significantly impacted sales . Investing in associated pharmaceutical companies now requires a discerning assessment of patent protection , evolving healthcare shifts , and the pos